Form 8-K - Current report:
SEC Accession No. 0001193125-23-010258
Filing Date
2023-01-18
Accepted
2023-01-18 17:00:05
Documents
12
Period of Report
2023-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d399403d8k.htm   iXBRL 8-K 23668
  Complete submission text file 0001193125-23-010258.txt   145472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230111.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230111_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230111_pre.xml EX-101.PRE 11275
6 EXTRACTED XBRL INSTANCE DOCUMENT d399403d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 23535015
SIC: 2834 Pharmaceutical Preparations